| dc.description.abstract | Neurocysticercosis (NCC) is the most common parasitic disease of
the central nervous system. Several drugs, such as drugs against tapeworms, praziquantel or
albendazole associated to corticosteroids, have been tested for the treatment of this condition.
Although some have claimed the reduction or involution of cystic or granulomatous lesions,
there is no consensus about the efficacy of these treatments. The natural evolution of the disease
is not clear and this hampers the assessment of treatment effects. Moreover, there are no good
imaging or clinical indicators that can predict the progression or spontaneous resolution of
lesions, specially at the meningeal or ventricular compartment. Therefore, evidence based
medicine does not have a definitive answer about the treatment, neither of seizures, the most
common manifestation of NCC, or the varied and complex meningeal and ventricular
involvement. This review includes experts opinions to give the clinician some clues for decision
making in the treatment of NCC. | |
